S100a9 is a biliary protein marker of disease activity in primary sclerosing cholangitis

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Reinhard, Lisa ^a   Rupp, Christian ^a   Riedel, Hans Dieter ^a   Ruppert, Thomas ^b   Giese, Thomas ^a   Flechtenmacher, Christa ^a   Weiss, Karl Heinz ^a   Kloeters Plachky, Petra ^a   Stremmel, Wolfgang ^a   Schirmacher, Peter ^a   Sauer, Peter ^a   Gotthardt, Daniel Nils ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN B; MESSENGER RNA; PANCREAS ENZYME; BIOLOGICAL MARKER; PROTEOME;

ADULT; ARTICLE; BILE; BILE DUCT CANCER; BRUSH CYTOLOGY; CELL INFILTRATION; CLINICAL ARTICLE; COMMON BILE DUCT STONE; CONTROLLED STUDY; CYTODIAGNOSIS; DENSITOMETRY; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE; LIQUID CHROMATOGRAPHY; MALE; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; BILE DUCT; CHEMISTRY; CYTOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; SCLEROSING CHOLANGITIS; UPREGULATION;

ADULT; BILE; BILE DUCTS; BIOLOGICAL MARKERS; CALGRANULIN B; CHOLANGITIS, SCLEROSING; CYTOLOGICAL TECHNIQUES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOME; UP-REGULATION;

EID: 84855690770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029821     Document Type: Article

References (36)

1. (2009) EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51: 237-267.
2. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, et al. (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51: 660-678.
3. Hirschfield GM, Heathcote EJ, (2009) Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 25: 175-179.
4. Mendes F, Lindor KD, (2010) Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol 7: 611-619.
5. Wagner M, Zollner G, Trauner M, (2009) New molecular insights into the mechanisms of cholestasis. J Hepatol 51: 565-580.
6. Blechacz B, Gores GJ, (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48: 308-321.
7. Gotthardt DN, Rudolph G, Kloters-Plachky P, Kulaksiz H, Stiehl A, (2010) Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc 71: 527-534.
8. Hofmann AF, (2007) Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 6: 15-27.
9. Lo Sasso G, Petruzzelli M, Moschetta A, (2008) A translational view on the biliary lipid secretory network. Biochim Biophys Acta 1781: 79-96.
10. Lankisch TO, Metzger J, Negm AA, Vobetakuhl K, Schiffer E, et al. (2010) Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology.
11. Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, et al. (2000) A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75: 688-694.
12. Hurkman WJ, Tanaka CK, (1986) Solubilization of plant membrane proteins for analysis by two-dimensional gel electrophoresis. Plant Physiol 81: 802-806.
13. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, et al. (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21: 1037-1053.
14. Gotthardt D, Blancheteau V, Bosserhoff A, Ruppert T, Delorenzi M, et al. (2006) Proteomics fingerprinting of phagosome maturation and evidence for the role of a Galpha during uptake. Mol Cell Proteomics 5: 2228-2243.
15. UniProt Consortium (2010) The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 38: D142-148.
16. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ, (1979) Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 77: 611-617.
17. LaRusso NF, (1984) Proteins in bile: how they get there and what they do. Am J Physiol 247: G199-205.
18. Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, et al. (2004) A proteomic analysis of human bile. Mol Cell Proteomics 3: 715-728.
19. Farina A, Dumonceau JM, Frossard JL, Hadengue A, Hochstrasser DF, et al. (2009) Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J Proteome Res 8: 159-169.
20. Zhou H, Chen B, Li RX, Sheng QH, Li SJ, et al. (2005) Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun Mass Spectrom 19: 3569-3578.
21. Guerrier L, Claverol S, Finzi L, Paye F, Fortis F, et al. (2007) Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins. J Chromatogr A 1176: 192-205.
22. Keulemans YC, Mok KS, de Wit LT, Gouma DJ, Groen AK, (1998) Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients. Hepatology 28: 11-16.
23. Farina A, Dumonceau JM, Delhaye M, Frossard JL, Hadengue A, et al. (2011) A step further in the analysis of human bile proteome. Journal of proteome research 10: 2047-2063.
24. Farid SG, Craven RA, Peng J, Bonney GK, Perkins DN, et al. (2011) Shotgun proteomics of human bile in hilar cholangiocarcinoma. Proteomics 11: 2134-2138.
25. Mullock BM, Hinton RH, (1981) Transport of proteins from blood to bile. Trends in Biochemical Sciences 6: 188-191.
26. Anderson NL, Anderson NG, (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867.
27. Green-Church KB, Nichols KK, Kleinholz NM, Zhang L, Nichols JJ, (2008) Investigation of the human tear film proteome using multiple proteomic approaches. Mol Vis 14: 456-470.
28. Reuben A, (1984) Biliary proteins. Hepatology 4: 46S-50S.
29. Saucan L, Palade GE, (1992) Differential colchicine effects on the transport of membrane and secretory proteins in rat hepatocytes in vivo: bipolar secretion of albumin. Hepatology 15: 714-721.
30. Fisher MM, Nagy B, Bazin H, Underdown BJ, (1979) Biliary transport of IgA: role of secretory component. Proc Natl Acad Sci U S A 76: 2008-2012.
31. Groen AK, Van Wijland MJ, Frederiks WM, Smit JJ, Schinkel AH, et al. (1995) Regulation of protein secretion into bile: studies in mice with a disrupted mdr2 p-glycoprotein gene. Gastroenterology 109: 1997-2006.
32. Gebhardt C, Nemeth J, Angel P, Hess J, (2006) S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72: 1622-1631.
33. Demetris AJ, Sever C, Kakizoe S, Oguma S, Starzl TE, et al. (1989) S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis? Am J Pathol 134: 741-747.
34. Nemeth J, Stein I, Haag D, Riehl A, Longerich T, et al. (2009) S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50: 1251-1262.
35. Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, et al. (2010) Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138: 1102-1111.
36. Beuers U, Hohenester S, de Buy Wenniger LJ, Kremer AE, Jansen PL, et al. (2010) The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 52: 1489-1496.